The NIH Center for Human Immunology, Inflammation, and Autoimmunity (CHI) is a trans-NIH resource whose mission is to provide a collaborative hub of advanced translational immunology for NIH clinical and pre-clinical studies. This uniquely structured program provides centralized and efficient management of projects in full collaboration with NIH investigators to better understand human immune function and pathophysiology. Our team works closely to plan and optimize experimental workflows tailored to each investigator’s specific research goals; execute highly sophisticated technological procedures on precious human samples; troubleshoot and optimize assays to generate high-quality data; seamlessly transfer data to our in-house informaticians who perform multimodal computational analyses; and provide expert scientific consultation, interpretations, and recommendations throughout the project lifecycle – all in one place.
The CHI operates in three modes: collaborative scientific studies, scientific technology development, and technology partnerships. Collaborative studies aim to leverage the high-dimensional technologies and expertise available in the CHI to enable systems-level characterization of immune phenotypes. Collaborative studies will be selected competitively from a call for proposal which is announced multiple times per year. Scientific study proposals can also be selected as a technology development project if the aims of the proposal don't match the criteria to be selected as a collaborative scientific study. Alternatively, a subset of the technologies at CHI are available to any NIH users through the CHI Technology Partnership Program (TPP) where CHI can generate data for a fee to cover costs, but study design and data analysis are the responsibility of the customer.